Soru

Zorluk: Çok zorNeurosurgery

Match each clinical and neuroimaging presentation of a suspected intracranial mass with its correct diagnostic entity and characteristic pathophysiological or histological feature.

  • Rapidly progressive cognitive decline and new-onset seizures. MRI reveals an irregularly enhancing hemispheric lesion crossing the corpus callosum.Glioblastoma; a high-grade neoplasm characterized histologically by microvascular proliferation and pseudopalisading necrosis.
  • Slowly progressive asymmetrical sensorineural hearing loss. MRI reveals an enhancing mass at the cerebellopontine angle extending into the internal auditory canal.Vestibular schwannoma; a benign peripheral nerve sheath tumor that arises from neural crest cells and commonly causes early tinnitus.
  • Gradual onset of focal motor seizures. MRI reveals a well-circumscribed, homogeneously enhancing extra-axial mass with a prominent 'dural tail'.Meningioma; a slow-growing tumor derived from arachnoid cap cells that often induces reactive hyperostosis in the overlying skull.
  • Prolonged history of refractory focal seizures in a young adult. Imaging shows a cortically based frontal lobe mass with prominent coarse calcifications.Oligodendroglioma; a slow-growing glioma frequently harboring 1p/19q1p/19q co-deletions and exhibiting a classic 'fried-egg' cellular appearance.
  • Progressive ataxia and headaches with concurrent secondary polycythemia. MRI reveals a cystic posterior fossa mass with a strongly enhancing mural nodule.Hemangioblastoma; a highly vascular stromal tumor capable of ectopic erythropoietin production, strongly associated with von Hippel-Lindau disease.

Cevap

The correct matches associate specific neuroimaging and clinical clues with the corresponding brain tumor: Butterfly glioma -> Glioblastoma; Cerebellopontine angle mass -> Vestibular Schwannoma; Dural tail -> Meningioma; Calcified frontal mass -> Oligodendroglioma; Cystic cerebellar nodule with polycythemia -> Hemangioblastoma.
Each vignette provides pathognomonic clinical and radiological clues that uniquely identify a specific intracranial tumor. Glioblastomas typically cross the midline ('butterfly' appearance). Vestibular schwannomas localize to the cerebellopontine angle and eighth cranial nerve. Meningiomas are extra-axial with a dural tail. Oligodendrogliomas are cortically based, calcified, and epileptogenic. Hemangioblastomas are cystic with a mural nodule and can cause paraneoplastic polycythemia.

Adım Adım Çözüm

1
Analyze each clinical vignette to identify the primary anatomical location and characteristic imaging findings.
Lesion 1 is transcallosal. Lesion 2 is at the cerebellopontine angle. Lesion 3 is extra-axial with a dural tail. Lesion 4 is a calcified frontal mass. Lesion 5 is a cystic cerebellar mass.
Tumor location and radiographic appearance are the primary drivers for neurosurgical differential diagnosis.
2
Synthesize the radiographic findings with the clinical history and systemic data.
Polycythemia points to a paraneoplastic process (erythropoietin). A long history of seizures suggests a low-grade, cortically based lesion. Rapid cognitive decline indicates a high-grade, infiltrative process.
Integrating systemic symptoms and symptom duration narrows the differential between benign/low-grade and highly malignant tumors.
3
Correlate the suspected clinical diagnosis with classic histological features and syndromic associations.
Glioblastoma matches pseudopalisading necrosis; Schwannoma matches neural crest origin; Meningioma matches arachnoid cap cells; Oligodendroglioma matches 1p/19q1p/19q deletion and 'fried-egg' cells; Hemangioblastoma matches von Hippel-Lindau syndrome and polycythemia.
Definitive diagnosis and management in neuro-oncology rely on matching imaging to underlying pathology and genetics.

Anahtar Kavram

Neuro-oncologic diagnosis relies on integrating clinical presentation, exact neuroanatomical location on imaging, and specific histopathological or molecular markers.
Bu soruyu puanla